# OnCo record takara-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/takara-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "takara-bio" ;
  schema:name "Takara Bio"@en ;
  schema:alternateName "Takara Bio Inc."@en, "タカラバイオ"@en ;
  schema:description "Takara Bio is a Japanese life-science tools company that also develops gene and cell therapies for cancer, including an oncolytic herpes virus and engineered T cells, and manufactures viral vectors for others."@en ;
  schema:url <https://onco.cc/companies/takara-bio/>, <https://www.takara-bio.co.jp> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.takara-bio.co.jp>, <https://clinicaltrials.gov/search?lead=Takara%20Bio%20Inc.>, <https://www.wikidata.org/wiki/Q11315991> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "JP" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/>, <https://onco.cc/technologies/tcr-t/>, <https://onco.cc/technologies/viral-vector-manufacturing/> ;
  onco:drugs <https://onco.cc/drugs/tbi-1301/>, <https://onco.cc/drugs/tbi-1501/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> ;
  onco:trials <https://onco.cc/trials/nct03155191/> .